MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 84 filers reported holding MERSANA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,740,566 | -58.5% | 2,157,665 | +7.6% | 0.00% | -100.0% |
| Q2 2023 | $6,598,693 | -10.7% | 2,005,682 | +11.5% | 0.00% | 0.0% |
| Q1 2023 | $7,393,261 | +73795.7% | 1,798,847 | +5.4% | 0.00% | 0.0% |
| Q4 2022 | $10,005 | -99.9% | 1,707,470 | +3.5% | 0.00% | -50.0% |
| Q3 2022 | $11,154,000 | +53.6% | 1,650,019 | +5.0% | 0.00% | +100.0% |
| Q2 2022 | $7,262,000 | +56.0% | 1,571,940 | +34.7% | 0.00% | 0.0% |
| Q1 2022 | $4,655,000 | -34.2% | 1,166,807 | +2.6% | 0.00% | 0.0% |
| Q4 2021 | $7,072,000 | -29.5% | 1,137,001 | +6.8% | 0.00% | 0.0% |
| Q3 2021 | $10,036,000 | -29.7% | 1,064,335 | +1.2% | 0.00% | -50.0% |
| Q2 2021 | $14,285,000 | -7.8% | 1,051,919 | +9.8% | 0.00% | 0.0% |
| Q1 2021 | $15,501,000 | -32.2% | 958,051 | +11.5% | 0.00% | -50.0% |
| Q4 2020 | $22,865,000 | +48.1% | 859,301 | +3.7% | 0.00% | +33.3% |
| Q3 2020 | $15,435,000 | -13.3% | 828,976 | +8.9% | 0.00% | -25.0% |
| Q2 2020 | $17,813,000 | +476.8% | 761,252 | +43.7% | 0.00% | +300.0% |
| Q1 2020 | $3,088,000 | -49.1% | 529,788 | -49.9% | 0.00% | 0.0% |
| Q4 2019 | $6,064,000 | +692.7% | 1,058,344 | +118.5% | 0.00% | – |
| Q3 2019 | $765,000 | -60.9% | 484,412 | +0.2% | 0.00% | – |
| Q2 2019 | $1,957,000 | +0.7% | 483,216 | +30.7% | 0.00% | -100.0% |
| Q1 2019 | $1,944,000 | +85.9% | 369,661 | +44.1% | 0.00% | – |
| Q4 2018 | $1,046,000 | -14.5% | 256,464 | +109.5% | 0.00% | – |
| Q3 2018 | $1,224,000 | -24.6% | 122,434 | +34.7% | 0.00% | – |
| Q2 2018 | $1,623,000 | +19.4% | 90,909 | +5.4% | 0.00% | – |
| Q1 2018 | $1,359,000 | +31.1% | 86,217 | +36.5% | 0.00% | – |
| Q4 2017 | $1,037,000 | +4.6% | 63,173 | +10.1% | 0.00% | – |
| Q3 2017 | $991,000 | – | 57,352 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |